ENANTA PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ENANTA PHARMACEUTICALS, INC (ENTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 23.00 thousand shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 10.00K shares, a 76.74% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 144.00K shares, a 171.70% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 43.00K shares, a 72.96% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 28.00K shares, a 62.16% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 232.00K shares, a 56.23% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 530.00K shares, a 97.03% increase from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 269.00K shares, a 13.98% increase from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 236.00K shares, a 29.67% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | 23.00K shares 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 13.00K shares 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | 144.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | 187.00K shares derived: sum of 2 quarters · filed 2025-11-19 | 215.00K shares derived: sum of 3 quarters · filed 2025-11-19 | 232.00K shares 10-K · filed 2025-11-19 | |
| 2025-06-30 | 43.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | 71.00K shares derived: sum of 2 quarters · filed 2025-08-13 | 88.00K shares 10-Q · filed 2025-08-13 | 141.00K shares derived: sum of 4 quarters · filed 2025-08-13 | |
| 2025-03-31 | 28.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | 45.00K shares 10-Q · filed 2025-05-14 | 98.00K shares derived: sum of 3 quarters · filed 2025-05-14 | 257.00K shares derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | 17.00K shares 10-Q · filed 2025-02-12 | 70.00K shares derived: sum of 2 quarters · filed 2025-02-12 | 229.00K shares derived: sum of 3 quarters · filed 2025-02-12 | 303.00K shares derived: sum of 4 quarters · filed 2025-02-12 | |
| 2024-09-30 | 53.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | 212.00K shares derived: sum of 2 quarters · filed 2024-11-27 | 286.00K shares derived: sum of 3 quarters · filed 2024-11-27 | 530.00K shares 10-K · filed 2024-11-27 | |
| 2024-06-30 | 159.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | 233.00K shares derived: sum of 2 quarters · filed 2024-08-07 | 477.00K shares 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | 74.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | 318.00K shares 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | 244.00K shares 10-Q · filed 2024-02-08 | ||||
| 2023-09-30 | 269.00K shares 10-K · filed 2023-11-22 | ||||
| 2023-03-31 | 125.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 169.00K shares 10-Q · filed 2023-08-08 | 82.00K shares 10-Q · filed 2023-05-09 | 256.00K shares derived: sum of 3 quarters · filed 2023-08-08 | 309.00K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | 44.00K shares 10-Q · filed 2023-02-08 | 131.00K shares derived: sum of 2 quarters · filed 2023-02-08 | 184.00K shares derived: sum of 3 quarters · filed 2023-02-08 | 246.00K shares derived: sum of 4 quarters · filed 2023-02-08 | |
| 2022-09-30 | 87.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | 140.00K shares derived: sum of 2 quarters · filed 2022-11-23 | 202.00K shares derived: sum of 3 quarters · filed 2022-11-23 | 236.00K shares 10-K · filed 2022-11-23 | |
| 2022-06-30 | 53.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | 115.00K shares derived: sum of 2 quarters · filed 2022-08-08 | 149.00K shares 10-Q · filed 2022-08-08 | 192.00K shares derived: sum of 4 quarters · filed 2022-08-08 | |
| 2022-03-31 | 62.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | 96.00K shares 10-Q · filed 2022-05-09 | 139.00K shares derived: sum of 3 quarters · filed 2022-05-09 | 173.00K shares derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-12-31 | 34.00K shares 10-Q · filed 2022-02-10 | 77.00K shares derived: sum of 2 quarters · filed 2022-02-10 | 111.00K shares derived: sum of 3 quarters · filed 2022-02-10 | 157.00K shares derived: sum of 4 quarters · filed 2022-02-10 | |
| 2021-09-30 | 43.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | 77.00K shares derived: sum of 2 quarters · filed 2021-11-24 | 123.00K shares derived: sum of 3 quarters · filed 2021-11-24 | 182.00K shares 10-K · filed 2021-11-24 | |
| 2021-06-30 | 34.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | 80.00K shares derived: sum of 2 quarters · filed 2021-08-09 | 139.00K shares 10-Q · filed 2021-08-09 | 184.00K shares derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | 46.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | 105.00K shares 10-Q · filed 2021-05-10 | 150.00K shares derived: sum of 3 quarters · filed 2021-05-10 | 203.00K shares derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | 59.00K shares 10-Q · filed 2021-02-09 | 104.00K shares derived: sum of 2 quarters · filed 2021-02-09 | 157.00K shares derived: sum of 3 quarters · filed 2021-02-09 | 234.00K shares derived: sum of 4 quarters · filed 2021-02-09 | |
| 2020-09-30 | 45.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | 98.00K shares derived: sum of 2 quarters · filed 2020-11-25 | 175.00K shares derived: sum of 3 quarters · filed 2020-11-25 | 198.00K shares 10-K · filed 2020-11-25 | |
| 2020-06-30 | 53.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | 130.00K shares derived: sum of 2 quarters · filed 2020-08-10 | 153.00K shares 10-Q · filed 2020-08-10 | 184.00K shares derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | 77.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | 100.00K shares 10-Q · filed 2020-05-11 | 131.00K shares derived: sum of 3 quarters · filed 2020-05-11 | 147.00K shares derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-12-31 | 23.00K shares 10-Q · filed 2020-02-10 | 54.00K shares derived: sum of 2 quarters · filed 2020-02-10 | 70.00K shares derived: sum of 3 quarters · filed 2020-02-10 | 96.00K shares derived: sum of 4 quarters · filed 2020-02-10 | |
| 2019-09-30 | 31.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | 47.00K shares derived: sum of 2 quarters · filed 2019-11-27 | 73.00K shares derived: sum of 3 quarters · filed 2019-11-27 | 79.00K shares 10-K · filed 2019-11-27 | |
| 2019-06-30 | 16.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | 42.00K shares derived: sum of 2 quarters · filed 2019-08-09 | 48.00K shares 10-Q · filed 2019-08-09 | 73.00K shares derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | 26.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | 32.00K shares 10-Q · filed 2019-05-10 | 57.00K shares derived: sum of 3 quarters · filed 2019-05-10 | 59.00K shares derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | 6.00K shares 10-Q · filed 2019-02-08 | 31.00K shares derived: sum of 2 quarters · filed 2019-02-08 | 33.00K shares derived: sum of 3 quarters · filed 2019-02-08 | 44.00K shares derived: sum of 4 quarters · filed 2019-02-08 | |
| 2018-09-30 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | 27.00K shares derived: sum of 2 quarters · filed 2018-11-29 | 38.00K shares derived: sum of 3 quarters · filed 2018-11-29 | 51.00K shares 10-K · filed 2018-11-29 | |
| 2018-06-30 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | 13.00K shares derived: sum of 2 quarters · filed 2018-08-09 | 26.00K shares 10-Q · filed 2018-08-09 | 31.34K shares derived: sum of 4 quarters · filed 2018-08-09 | |
| 2018-03-31 | 11.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | 24.00K shares 10-Q · filed 2018-05-10 | 29.34K shares derived: sum of 3 quarters · filed 2018-05-10 | 56.40K shares derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | 13.00K shares 10-Q · filed 2018-02-09 | 18.34K shares derived: sum of 2 quarters · filed 2018-02-09 | 45.40K shares derived: sum of 3 quarters · filed 2018-02-09 | 148.97K shares derived: sum of 4 quarters · filed 2018-02-09 | |
| 2017-09-30 | 5.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | 32.40K shares derived: sum of 2 quarters · filed 2017-12-11 | 135.97K shares derived: sum of 3 quarters · filed 2017-12-11 | 138.00K shares 10-K · filed 2017-12-11 | |
| 2017-06-30 | 27.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | 130.63K shares derived: sum of 2 quarters · filed 2017-08-09 | 132.66K shares 10-Q · filed 2017-08-09 | 141.28K shares derived: sum of 4 quarters · filed 2017-08-09 | |
| 2017-03-31 | 103.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | 105.60K shares 10-Q · filed 2017-05-10 | 114.22K shares derived: sum of 3 quarters · filed 2017-05-10 | 131.12K shares derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | 2.03K shares 10-Q · filed 2017-02-09 | 10.66K shares derived: sum of 2 quarters · filed 2017-02-09 | 27.55K shares derived: sum of 3 quarters · filed 2017-02-09 | 43.66K shares derived: sum of 4 quarters · filed 2017-02-09 | |
| 2016-09-30 | 8.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | 25.52K shares derived: sum of 2 quarters · filed 2016-12-09 | 41.63K shares derived: sum of 3 quarters · filed 2016-12-09 | 47.16K shares 10-K · filed 2016-12-09 | |
| 2016-06-30 | 16.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 33.00K shares derived: sum of 2 quarters · filed 2016-08-09 | 38.53K shares 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 16.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | 21.64K shares 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | 5.53K shares 10-Q · filed 2016-02-09 | ||||
| 2015-09-30 | 41.92K shares 10-K · filed 2015-12-11 | ||||
| 2014-09-30 | 7.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | 7.63K shares derived: sum of 2 quarters · filed 2014-12-11 | 16.91K shares 10-K · filed 2014-12-11 | ||
| 2014-06-30 | 64.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | 9.34K shares 10-Q · filed 2014-08-12 | |||
| 2014-03-31 | 9.28K shares 10-Q · filed 2014-05-12 | ||||
| 2013-09-30 | 11.32K shares 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |